2018: Market size — $5.6 billion
At the beginning of February, 2019 the MarketsandMarkets analytical company published results of a research of the world market of the radiotherapeutic systems. Sales of such solutions in 2018 reached $5.6 billion, to the 2023rd the indicator will reach $6.8 billion, and annual average growth rates of the market will be measured by 4.1%.
Demand for the equipment for radiation therapy increases owing to several factors, such as the growing spread of oncological diseases in the world, technology achievements, emerging markets, the growing state and private investments into projects of cancer therapy and improvement of a situation with payment of compensations by the patient.
On the other hand, the lack of adequate infrastructure of health care, the shortage of highly skilled personnel, limited availability of treatment and also the difficult nature of radiation therapy, as expected, will limit market growth. Difficulties with visualization of tumors during the procedures of radiation therapy and possible negative effects of radiation exposure can also create problems also prevent sales of the radiotherapeutic equipment.
The largest producers of such equipment experts call the following companies:
- Varian Medical Systems (USA);
- Elekta (Sweden);
- Accuray (USA).
Also in a research the names of the following producers are told:
- Ion Beam Applications (Belgium);
- ViewRay (USA);
- IsoRay Medical (USA); Hitachi (Japan);
- Panacea Medical Technologies (India);
- Provision Healthcare (США);
- Mevion Medical Systems (США);
- Sumitomo Heavy Industries (Japan);
- Optivus Proton Therapy (США);
- P-cure (Israel);
- Theragenics Corporation (США);
- C.R. Bard (USA).
MarketsandMarkets says that market participants develop different strategy for business growth, including release new products and improve operating. Besides, strategic acquisitions for strengthening of the product portfolio and maintenance of a competitive position in the market of radiotheraphy are made.[1]